Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/2029405]Funding Amount $888,649.68
Full description We aim to develop a novel antibody-based therapeutic to target a cell surface protein (CRLF2) that is vital for the survival of a high-risk leukaemia subtype. This novel approach will reduce the likelihood of relapse associated with loss of the cell surface target. Besides targeted drug delivery, this multipronged therapeutic approach will disrupt the function of CRLF2 and recruit the body’s own immune system against cancer cells thus improving the treatment of high-risk patients.
Chief Investigator Prof Richard Lock
Date Announced 2023-12-15T00:00:00
Sector University
Spatial Coverage And Location
text: NSW
- nhmrc : 2029405
- PURL : https://purl.org/au-research/grants/nhmrc/2029405
